Cangrelor 50 mg Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg
Reference Brands: Kengreal (USA/EU)
Category: Heart Disorder
Cangrelor is a Heart Disorder product available as Injection in strengths 50 mg. It corresponds to the reference brand Kengreal (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Cangrelor is a potent, fast-acting intravenous antiplatelet agent approved for use in patients undergoing percutaneous coronary intervention (PCI). It is indicated to reduce the risk of thrombotic cardiovascular events in patients who have not been treated with oral P2Y12 inhibitors or who are unable to receive oral antiplatelet therapy. The clinical efficacy of cangrelor is attributed to its direct, reversible inhibition of the P2Y12 platelet receptor, resulting in rapid and consistent platelet inhibition.
Cangrelor is characterized by an immediate onset of action and a very short half-life, allowing for precise control of antiplatelet effects during and immediately after PCI. Its pharmacokinetic and pharmacodynamic profile enables quick recovery of platelet function once the infusion is discontinued, making it suitable for use in acute and procedural settings.
The drug is generally well tolerated, though healthcare professionals should remain aware of potential adverse drug reactions, contraindications, and drug interactions associated with antiplatelet therapy. Proper patient selection, dosing, and monitoring are essential to optimize clinical outcomes. Effective interprofessional collaboration among cardiologists, pharmacists, and nursing staff plays a critical role in ensuring the safe and effective use of cangrelor in cardiovascular care.
Cangrelor — third party manufacturing & bulk supply
Cangrelor 50 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Cangrelor listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Cangrelor →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Cangrelor is used as an intravenous antiplatelet agent to reduce the risk of thrombotic cardiovascular events in patients undergoing percutaneous coronary intervention (PCI). It is especially useful in patients who have not been pretreated with oral P2Y12 inhibitors or who are unable to take oral antiplatelet therapy.
Cangrelor is a synthetic adenosine triphosphate analog. It is chemically designed to reversibly inhibit platelet activation by targeting the P2Y12 receptor.
Cangrelor is marketed under the trade names Kengreal in the United States and Kengrexal in the European Union and the United Kingdom.
Cangrelor was developed by The Medicines Company. It is currently marketed by Chiesi Farmaceutici in the EU and UK, and by Chiesi USA for the US market.
The generic name is cangrelor.
The brand names are Kengreal and Kengrexal.
Cangrelor is manufactured in GMP-approved pharmaceutical facilities, with production and supply distributed across the USA and Europe according to regional regulatory approvals.
Related Products
Trandolapril
Strength:
0.5 mg, 1 mg, 2 mg
Form: Tablets
Reference Brands: Mavik (USA), Gopten (EU)
View Details
Tirofiban Hydrochloride
Strength:
2.5 mg/mL
Form: Injection
Reference Brands: Aggrastat (USA)
View Details
Selexipag
Strength:
200 mcg, 400 mcg, 600 mcg, 800 mcg, 1000 mcg, 1200 mcg, 1400 mcg, 1600 mcg
Form: Tablets / Injection
Reference Brands: Uptravi (USA/EU)
View Details
Edoxaban
Strength:
15 mg, 30 mg, 60 mg
Form: Tablets
Reference Brands: Savaysa (USA), Lixiana (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
